Publications by authors named "Lambert Busque"

Claim this Profile
I
In low-risk myelodysplastic syndrome, don't shoot the STAG2.
Natasha Szuber, Lambert Busque

Blood· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes of high-risk patients with polycythemia vera after suboptimal response to first-line therapy who switched to ruxolitinib versus nonswitchers: results from the PV-Switch study.
Steffen Koschmieder, Clemens Schulte, Eyck von der Heyde, Lambert Busque, Françoise Boyer-Perrard

Ther Adv Hematol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A plain language summary of the ASCERTAIN trial: oral decitabine and cedazuridine versus intravenous decitabine for MDS or CMML.
Guillermo Garcia-Manero, James McCloskey, Elizabeth A Griffiths, Karen W L Yee, Amer M Zeidan, Lambert Busque

Future Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Symptom burden in myeloproliferative neoplasms: clinical correlates, dynamics, and survival impact-a study of 784 patients from the Quebec MPN research group.
Alisa Poullet, Lambert Busque, Shireen Sirhan, Robert Delage, Ghislain Cournoyer

Blood Cancer J· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved identification of clinically relevant Acute Leukemia subtypes using standardized EuroFlow panels versus non-standardized approach.
Rafik Terra, Vincent Éthier, Lambert Busque, Ariane Morin-Quintal, Giovanni D'Angelo

Cytometry B Clin Cytom· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibrosis and treatment-free remission in chronic myeloid leukaemia.
Eugene Brailovski, Michaël Harnois, Lambert Busque, Ines Chamakhi, Anouk Tremblay

Br J Haematol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching TKIs during CML therapy is frequent, mostly driven by intolerance, and does not affect survival: a prospective Quebec registry study.
Lambert Busque, Marc-Étienne Beaudet, Michaël Harnois, Hanane Moussa, Natasha Szuber

Blood Cancer J· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient and physician perceptions regarding treatment expectations and symptomatology in polycythemia vera: Insights from the Landmark 2.0 global health survey.
Claire N Harrison, David M Ross, Laura Maria Fogliatto, Lynda Foltz, Lambert Busque

Hemasphere· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing CAR-T Efficacy in Large B-Cell Lymphoma with Radiation Bridging Therapy: A Real-World Single-Center Experience.
Eva Laverdure, Luigina Mollica, Imran Ahmad, Sandra Cohen, Silvy Lachance, Lambert Busque

Curr Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative outcomes in patients with myeloproliferative neoplasms: a multicentric analysis of 354 surgical procedures.
Natasha Szuber, Harold J Olney, Steve Dagenais Bellefeuille, Mégane Tanguay, Awatef Shehabeldeen, Lambert Busque

Blood Vessel Thromb Hemost· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Childhood Maltreatment and Leukocyte Telomere Length: Cardiac Vagal Activity Influences the Relation in Older Adults.
Alexandra Connor, Alain Deschamps, Lambert Busque, Jean-Claude Tardif, Vincent Bourgoin

Psychosom Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CALR mutation burden in essential thrombocythemia and disease outcome.
Paola Guglielmelli, Natasha Szuber, Naseema Gangat, Giulio Capecchi, Chiara Maccari, Lambert Busque

Blood· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral decitabine-cedazuridine versus intravenous decitabine for myelodysplastic syndromes and chronic myelomonocytic leukaemia (ASCERTAIN): a registrational, randomised, crossover, pharmacokinetics, phase 3 study.
Guillermo Garcia-Manero, James McCloskey, Elizabeth A Griffiths, Karen W L Yee, Amer M Zeidan, Lambert Busque

Lancet Haematol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final report of TKI discontinuation trial with dasatinib for the second attempt of treatment-free remission after failing the first attempt with imatinib: Treatment-free Remission Accomplished by Dasatinib (TRAD) study.
Maria Agustina Perusini, Igor Novitzky-Basso, Eshetu G Atenafu, Donna Forrest, Isabelle Bence-Bruckler, Lambert Busque

Br J Haematol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of progression in chronic phase-chronic myeloid leukemia patients eligible for tyrosine kinase inhibitor discontinuation: Final analysis of the TFR-PRO study.
Giovanni Paolo Maria Zambrotta, Franck E Nicolini, Sarit Assouline, Lambert Busque, Ester Pungolino

Am J Hematol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Childhood maltreatment and leukocyte telomere length in men and women with chronic illness: an evaluation of moderating and mediating influences.
Alexandra Connor, Louisia Starnino, Lambert Busque, Jean-Claude Tardif, Vincent Bourgoin

Psychol Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Canadian real-world experience of asciminib treatment in heavily pre-treated chronic myeloid leukemia (CML) patients who failed multiple lines of tyrosine kinase inhibitor (TKI) therapy.
Fatima M Khadadah, Sonia Cerquozzi, Harold J Olney, Christina Fraga, Jill Dudebout, Lambert Busque

Leuk Res· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interplay between hereditary and acquired factors determines the neutrophil counts in older individuals.
Marie-France Gagnon, Sylvie Provost, Maxine Sun, Sami Ayachi, Manuel Buscarlet, Lambert Busque

Blood Adv· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors.
Maxine Sun, Marie-Christyne Cyr, Johanna Sandoval, Louis-Philippe Lemieux Perreault, Lambert Busque

Cancer Epidemiol Biomarkers Prev· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blasts in context: the impact of the immune environment on acute myeloid leukemia prognosis and treatment.
Yasmina Serroukh, Josée Hébert, Lambert Busque, François Mercier, Christopher E Rudd

Blood Rev· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative management of myeloproliferative neoplasms: A pan-Canadian physician survey and international expert opinion.
Natasha Szuber, Panagiota Toliopoulos, Lambert Busque, Sonia Cerquozzi, Lynda Foltz

Am J Hematol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined PD-L1 and TIM3 blockade improves expansion of fit human CD8 antigen-specific T cells for adoptive immunotherapy.
Shirin Lak, Valérie Janelle, Anissa Djedid, Gabrielle Boudreau, Ann Brasey, Lambert Busque

Mol Ther Methods Clin Dev· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A macaque clonal hematopoiesis model demonstrates expansion of TET2-disrupted clones and utility for testing interventions.
Tae-Hoon Shin, Yifan Zhou, Shirley Chen, Stefan Cordes, Max Z Grice, Lambert Busque

Blood· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two types of human TCR differentially regulate reactivity to self and non-self antigens.
Assya Trofimov, Philippe Brouillard, Jean-David Larouche, Jonathan Séguin, Jean-Philippe Laverdure, Lambert Busque

iScience· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.
Joseph D Khoury, Eric Solary, Oussama Abla, Yassmine Akkari, Rita Alaggio, Lambert Busque

Leukemia· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis